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a b s t r a c t
The Brazilian human borreliosis, also known as Baggio-Yoshinari Syndrome (BYS), is a tick-
borne disease but whose ticks do not pertain to the Ixodes ricinus complex. It is caused 
by Borrelia burgdorferi sensu lato microorganisms and resembles clinical and laboratory 
features of Lyme disease (LD). BYS is also distinguished from LD by its prolonged clinical 
evolution, with relapsing episodes and autoimmune dysfunction. We describe the case of 
a young female who, over one year, progressively presented with oligoarthritis, cognitive 
impairment, menigoencephalitis and erythema nodosum. Diagnosis was established by 
means of the clinical history and a positive serology to Borrelia burgdorferi sensu strictu. The 
patient received Ceftriaxone 2 g IV/day during 30 days, followed by 2 months of doxicy-
cline 100 mg bid. Symptoms remitted and the Borrelia serology tests returned to normality. 
BYS is a new disease described only in Brazil, which has a raising frequency and deserves 
the attention from the country´s medical board because of clinical, epidemiological and 
laboratory differences from LD. Despite the fact that it is a hard-to-diagnose zoonosis, it is 
important to pursuit an early diagnosis because the symptoms respond well to antibiotics 
or it might be resistant to treatment and may evolve to a chronic phase with both articular 
and neurological sequelae.
© 2014 Elsevier Editora Ltda. All rights reserved.
☆ Study conducted at Service of Rheumatology, Hospital das Clínicas, Medicine School, Universidade de São Paulo (HC-FMUSP), São Paulo, SP, Brazil.
* Corresponding author.
E-mail: nsalles@yahoo.com (N.S. Rosa-Neto).
0482-5004/$ - see front matter. © 2014 Elsevier Editora Ltda. All rights reserved.
http://dx.doi.org/10.1016/j.rbre.2014.03.010
2255-5021
149R E V  B R A S  R E U M A T O L .  2 0 1 4 ; 5 4 ( 2 ) : 1 4 8 – 1 5 1
Meningoencefalite linfomonocitária crônica, oligoartrite e eritema 







Doenças transmitidas por 
carrapatos
r e s u m o
A borreliose humana brasileira, também conhecida como Síndrome de Baggio-Yoshinari 
(SBY), é uma enfermidade infecciosa própria do território brasileiro, transmitida por car-
rapatos não pertencentes ao complexo Ixodes ricinus, causada por espiroqueta do gênero 
Borrelia e que apresenta semelhanças clínicas e laboratoriais com a Doença de Lyme (DL). 
A SBY distingue-se da DL por apresentar evolução clínica prolongada, com episódios de 
recorrência e importante disfunção autoimune. Descreveremos o caso de uma paciente 
jovem, que desenvolveu progressivamente durante cerca de um ano oligoartrite de gran-
des articulações, seguida de distúrbio do cognitivo, meningoencefalite e eritema nodoso. O 
diagnóstico foi firmado devido à concomitância de queixas articulares e neurológicas com 
sorologia positiva para Borrelia burgdorferi sensu stricto. A paciente foi medicada com ceftria-
xone 2 g/EV/dia por 30 dias, seguido de dois meses de doxiciclina 100 mg duas vezes ao dia. 
Houve remissão dos sintomas e normalização dos exames sorológicos para a borreliose. A 
SBY é uma zoonose emergente descrita apenas no Brasil, cuja frequência tem crescido bas-
tante, e que, em razão das importantes diferenças nos aspectos epidemiológicos, clínicos e 
laboratoriais em relação à DL, merece especial atenção da classe médica do país. Trata-se 
de zoonose camuflada e de difícil diagnóstico, mas este deve ser perseguido com tenacida-
de, pois a enfermidade responde aos antibióticos no estágio inicial, podendo evoluir com 
sequelas neurológicas e articulares nos casos reconhecidos tardiamente ou recorrentes.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.
Introduction
Brazilian human borreliosis or Baggio-Yoshinari Syndrome 
(BYS) is an endemic anthropozoonosis proper to Brazil, caused 
by spirochetes of the genus Borrelia, transmitted by ticks of the 
genus Amblyomma and Rhipicephalus, which have clinical simi-
larities with Lyme disease (LD).1-8 BYS can be distinguished 
from LD, since the transmission vectors for this latter disease 
belong to the Ixodes ricinus species. Furthermore, from a clini-
cal standpoint, this Brazilian disease evolves with symptom-
atic and immunological disorder recurrence.1,5-7
Researchers at the Medical Research Laboratory, Medicine 
School, Universidade de São Paulo (LIM -17) suggest that the 
biodiversity conditions  particular to the Brazilian territory, 
such as the presence of exotic vectors and favorable ecologi-
cal conditions, have allowed for bacteria of the Borrelia burg-
dorferi complex sensu lato, to adapt to the country1,6,7,9 and de-
velop a zoonosis with typical clinical and laboratory aspects. 
The dissemination of clinical and laboratory knowledge 
about BYS has been a great challenge, because even with a 
different clinical and laboratory picture of LD, there is huge 
resistance from national and international scholars to admit 
the existence of this Brazilian zoonosis. Concepts such as pro-
longed latent infection caused by spirochetes in the form of 
cysts, clinical recurrence, different serologic diagnosis from 
standards adopted by the Centers for Disease Control and Pre-
vention (CDC), and the therapeutic strategies for use of anti-
biotics during extended periods of time are not acceptable for 
certain countries of the northern hemisphere.
However, to deny its existence as an emerging clinical en-
tity would be gross negligence, especially when there is evi-
dence that the disease may progress to develop severe joint 
and neurological sequelae, if not treated properly.6,10 In this 
paper, we describe an illness of prolonged evolution and re-
current symptoms, in that the diagnosis of BYS was estab-
lished after the onset of meningoencephalitis with positive 
serology for B. burgdorferi, according to LIM-17 adopted stan-
dards.
Case report
Female, 35 years old, white, coming from the city of Cotia, 
São Paulo, where she lives since childhood. At 23, the pa-
tient showed additive polyarthritis, affecting hands, elbows, 
shoulders, knees and ankles. She recounts being treated with 
benzathine penicillin after hypothesis of rheumatic fever; 
however, due to the persistence of symptoms, she sought a 
rheumatologist who diagnosed rheumatoid arthritis, being 
treated with sulfasalazine, with improvement. She ceased 
medication after five years of clinical remission. She denied 
having erythema migrans (EM) and an infectious or surgi-
cal history. In June 2006 the patient displayed arthritis in her 
knees and left ankle, with erythematous spots on her legs. 
The case evolved to slow logical reasoning, amnesia for recent 
events, nervousness, depression and difficulty planning activ-
ities, dysgraphia, loss of balance and appearance of intermit-
tent diplopia episodes with an increasing visual impairment. 
She reported febrile episodes (unmeasured). The patient lives 
in an urban area with dogs at home, but always goes to a farm 
in Ibiuna, Sao Paulo, where horses and cows are raised. The 
patient did not recall tick bites in the past 12 months, but re-
lates that it had occurred several times before.
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In December 2006 the patient was admitted for evaluation 
of cerebellar ataxia and neuritis of the 2nd cranial nerve. On 
admission, she was in good general condition, pale, normo-
tensive and afebrile, without lymphadenomegaly. Upon in-
spection, the patient had hyperchromic macules, with palpa-
ble nodules in the anterior region of both legs, with no other 
mucocutaneous lesions. Cardiopulmonary and abdominal 
workup revealed no changes. 
Arthritis showed up on her knees and left ankle, with pres-
ervation of small joints, without joint limitation or deformities.
The patient was lucid and oriented in time and space, alert 
and cooperative, amnesic to recent events, but with remote 
memory preserved. A nontoxic march with grade V driving 
force in all members was observed, with a mild dysmetria 
of the left arm. Sensitivity and reflexes were preserved and 
there was no sign of meningeal irritation.
Laboratory tests revealed normocytic and normochromic 
anemia, erythrocyte sedimentation rate = 85 mm/1st hour 
and  C-reactive protein = 99 mg/L. The tuberculin test was 
negative, as well as antinuclear and rheumatoid factors. A 
CSF analysis revealed pleocytosis at the expense of lympho-
monocytic cells. Search for infectious and parasitic agents 
(toxoplasmosis, tuberculosis, hepatitis B and C, herpes sim-
plex, cytomegalovirus, cysticercosis, HIV, HTLV, mumps, cryp-
tococcosis, trypanosomiasis, malaria) were negative in serum 
and CSF. The magnetic resonance imaging revealed enlarge-
ment of the basal cisterns, with a hyperintense signal on T2 
and FLAIR at cerebral white matter, in the precentral gyrus at 
the left and in orbital gyrus at the right, without anomalous 
impregnation after the contrast.
Spontaneous neurological improvement was noted; after-
wards, the patient was referred for outpatient follow-up. The 
CSF samples confirmed the diagnosis as chronic lymphocytic 
meningoencephalitis (Table 1). 
In April 2007 the patient had intermittent episodes of dip-
lopia and skin lesions, whose biopsy showed chronic septal 
panniculitis consistent with erythema nodosum. Serology for 
B. burgdorferi was requested, including ELISA IgM/IgG 1/800 re-
agent negative and a Western blot that revealed presence of 
one IgM band and 3 IgG bands.
Given the clinical laboratory and epidemiological charac-
teristics, the diagnosis of BYS was established. Ceftriaxone 2 
g/day for 30 days was introduced, followed by doxycycline 200 
mg/day for two months. There was improvement in the cog-
nitive dysfunction at the end of the first cycle of antibiotics, 
with disappearance of erythema nodosum and arthritis reso-
lution. Due to the persistence of cerebellar dysfunction, the 
patient was readmitted for investigation in July 2007.
The neurological examination revealed decreased speed 
of movement to the left, dysdiadocokinesia, intention tremor 
and nystagmus evoked to the left. The neuropsychological as-
sessment showed impairment in information processing as 
well as nominative and visual-spatial difficulties. Then, we 
decided to prescribe five days of pulse therapy with methyl-
prednisolone 1 g, followed by five days of prednisone 60 mg/
day. Doxycycline was maintained for 60 days, in association 
with 250 mg of chloroquine diphosphate. The serology for B. 
burgdorferi became negative during the evolution, according to 
data from Table 2. 
Currently, the patient is asymptomatic, without changes 
in the brain resonance, but with some memory impairment.
Discussion
In this paper, the case of a patient with late diagnosed BYS 
and with severe neurological injury associated with joint and 
cutaneous manifestations is presented. A positive serology for 
B. burgdorferi (sensu stricto) helped confirm the diagnosis. Posi-
tive epidemiological history, presence of cognitive impairment 
and neuropsychiatric symptoms, along with a good response to 
treatment with disappearance of antibodies anti-spirochetes, 
were equally relevant to the diagnosis.
In Brazil, this zoonosis may have a long latency period be-
tween initial infection and the onset of symptoms, as well as 
with relapsing episodes during its evolution. Generally, the joint 
condition of BYS emerges in large joints, especially the knees, 
and can evolve to simulate rheumatoid arthritis, as it was in 
this case.5,6,8 In this country, whenever there is presence of oli-
goarthritis of large joints, an investigation of BYS is mandatory, 
and one should search both the  epidemiological and clinical 
histories.
LIM-17 adopts as diagnostic criteria for BYS the presence of 
major (positive epidemiology, MS or systemic symptoms, and 
positive serology) and minor (a history of systemic episodes 
compatible with BYS, symptoms of chronic fatigue or cognitive 
dysfunction, autoimmune disorders and visualization of spiro-
chetes in peripheral blood) parameters.11 The patient visited risk 
Table 1 – Evolutionary analysis of the cerebrospinal fluid (CSF).












Date Dec 13, 06 Dec 15, 06 Mar 19, 07 Apr 04, 07 July 13, 07 July 30, 07
Leukocytes (/mm3) 0 - 5 960 160 65 81 190 18
Neutrophils 1 3 7 42 6 0
Lymphocytes 94 90 76 41 73 67
Monocytes 3 6 17 15 19 21
Glucose (mg/dL) 50 - 90 41 44 55 48 63 80
Proteins (mg/dL) < 40 62 49 38 43 32 30
B. burgdorferi 
ELISA IgM - - - Negative Negative -
ELISA IgG - - - Negative Negative -
Ref, reference value.
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areas, socialized with domestic animals and had episodes of tick 
bites. The BYS vectors often infest animals living close to man.1,6 
The fact that the patient denied recent tick bites is not surpris-
ing, as the contagion may have occurred months or years before 
the current symptoms.
The concomitant occurrence of meningoencephalitis and 
the involvement of the second cranial nerve, associated with the 
joint manifestation, is a relevant aspect. Shinjo et al.,10 studied 
30 patients with BYS neuroborreliosis, and found that 73.6% had 
recurrence episodes, 56.7% had concomitant neurologic com-
plaints with arthritis, and meningoencephalitis was identified 
in 33.3% of cases. 
The encephalomyelitis of human borreliosis may be con-
fused with multiple sclerosis (EM).12,13 In this report, the exuber-
ance of the inflammatory symptoms, the multiplicity of system-
ic complaints, a positive serology for B. burgdorferi and the good 
response to antibiotics excluded this diagnostic option. Other 
causes of infectious and autoimmune encephalomyelitis were 
also excluded.
There is no mention about MS in our patient's history, but it 
should be noted that this initial injury, which arises at the point 
of inoculation of spirochetes, occurs in less than 50% of cases 
in Brazil.6,8 Interestingly, other atypical cutaneous presentations 
have been reported, such as panniculitis, lymphocytoma and 
scleroderma-like plate.6,8,11,14 There is no record of erythema no-
dosum associated with BYS, but there are reports of erythema 
nodosum in patients with LD.15
This paper confirms the existence of recurring outbreaks in 
BYS patients. This finding is highly relevant, since the current 
symptoms are not always associated with epidemiological and 
clinical data of the past. However, due to the severity of illness, a 
good response of the condition to the treatment with antibiotics 
in its early stages, and the possibility of preventing progression 
to chronicity, physicians of different specialties should be vigi-
lant for suspected cases of Brazilian human borreliosis.
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Ceftriaxone was initiated on June 29, 2007.
